Sean Grant - 23 Jun 2023 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
Chief Financial Officer
Signature
/s/ Joseph R. Young, Attorney-in-Fact
Issuer symbol
VERA
Transactions as of
23 Jun 2023
Net transactions value
+$83,000
Form type
4
Filing time
23 Jun 2023, 16:05:01 UTC
Previous filing
05 Apr 2024
Next filing
18 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERA Class A Common Stock Purchase $83,000 +5,000 +504% $16.60 5,992 23 Jun 2023 By Trust
holding VERA Class A Common Stock 49,933 23 Jun 2023 Direct
holding VERA Class A Common Stock 2,816 23 Jun 2023 By IRA
holding VERA Class A Common Stock 335 23 Jun 2023 By Roth IRA
holding VERA Class A Common Stock 857 23 Jun 2023 By Spouse's IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.